Get the Stockscreener App
4.13
1.20%
-0.05
Health Catalyst Inc stock is traded at $4.13, with a volume of 485.61K.
It is down -1.20% in the last 24 hours and up +2.74% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$4.18
Open:
$4.18
24h Volume:
485.61K
Relative Volume:
0.68
Market Cap:
$291.57M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-2.7533
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
-1.43%
1M Performance:
+2.74%
6M Performance:
-49.88%
1Y Performance:
-38.08%
1-Day Range:
$4.08
$4.32
1-Week Range:
$3.80
$5.062
52-Week Range:
$3.555
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
4.13 | 291.57M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
237.05 | 38.54B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.19 | 11.13B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
61.37 | 9.87B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
90.40 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
40.01 | 7.04B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2025 Earnings Call Transcript - Insider Monkey
Health Catalyst, Inc. (NASDAQ:HCAT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
Health Catalyst (HCAT): Analyst Maintains Buy Rating, Lowers Price Target | HCAT Stock News - GuruFocus
Health Catalyst (HCAT) Target Price Raised by Stifel Analyst | HCAT Stock News - GuruFocus
Breaking Down Health Catalyst: 9 Analysts Share Their Views - Benzinga
Canaccord cuts Health Catalyst price target to $9, maintains buy By Investing.com - Investing.com Australia
Evercore ISI lifts Health Catalyst stock to $5 target By Investing.com - Investing.com Canada
Canaccord cuts Health Catalyst price target to $9, maintains buy - Investing.com
Canaccord Adjusts Price Target for Health Catalyst (HCAT), Remains Optimistic | HCAT Stock News - GuruFocus
Evercore ISI lifts Health Catalyst stock to $5 target - Investing.com
Detailed Analysis of Population Based Health Services Market | - openPR.com
Health Catalyst: Q1 Earnings Snapshot - MySA
Health Catalyst (HCAT) Surpasses Q1 Revenue and Earnings Projections | HCAT Stock News - GuruFocus
Health Catalyst Inc Reports Q1 2025 Earnings: EPS of -$0.35 Miss - GuruFocus
Earnings call transcript: Health Catalyst beats Q1 2025 EPS forecast, stock rises - Investing.com
Health Catalyst earnings beat, revenue topped estimates - Investing.com
Health Catalyst (NASDAQ:HCAT) Posts Q1 Sales In Line With Estimates, Stock Soars - Yahoo
Health Catalyst (HCAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Health Catalyst (HCAT) Q1 Earnings Meet Estimates - Yahoo Finance
Health Catalyst (HCAT) Projects FY25 Adjusted EBITDA of $41 Million | HCAT Stock News - GuruFocus
Health Catalyst Reports First Quarter 2025 Results - The Manila Times
Health Catalyst (HCAT) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Health Catalyst Inc expected to post breakeven results a shareEarnings Preview - TradingView
Hims & Hers Health (HIMS) Stock Jumps 23.0%: Will It Continue to Soar? - Nasdaq
Health Catalyst Announces Strategic Partnership with Microsoft t - GuruFocus
Health Catalyst, Microsoft Collaborate to Accelerate AI Adoption in Healthcare - marketscreener.com
Health Catalyst (HCAT) Partners with Microsoft to Boost AI-Drive - GuruFocus
Health Catalyst Announces Strategic Partnership With Microsoft - marketscreener.com
Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations - Longview News-Journal
Citi Adjusts Price Target for Health Catalyst (HCAT) Amid Earnin - GuruFocus
Q4 Earnings Outperformers: Health Catalyst (NASDAQ:HCAT) And The Rest Of The Data Analytics Stocks - Yahoo Finance
Cadence, DocuSign, Health Catalyst, UiPath, and Amplitude Shares Are Soaring, What You Need To Know - Yahoo Finance
Pure Storage, Health Catalyst, AMD, Micron, and FormFactor Stocks Trade Up, What You Need To Know - MSN
Patient Engagement Software Market Deep Research Report with - openPR.com
Best Statistical Healthcare Cognitive Analytics Market Growth - openPR.com
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025 - The Manila Times
Healthcare Analytics Leader Health Catalyst Sets Q1 2025 Earnings Release Date - Stock Titan
Health Catalyst stock hits 52-week low at $3.56 amid market challenges By Investing.com - Investing.com South Africa
Health Catalyst stock hits 52-week low at $3.56 amid market challenges - Investing.com India
KeyBanc Adjusts Price Target for Health Catalyst (HCAT) Ahead of Q1 Earnings | HCAT Stock News - GuruFocus
Cantor Fitzgerald maintains overweight rating on Health Catalyst stock By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains overweight rating on Health Catalyst stock - Investing.com
Healthcare Data Analytics Market Is Booming Worldwide 2025-2032 | Health Catalyst, Oracle, Optum, SAS - openPR.com
HIMSSCast: "How do we grow again?" - Healthcare Finance News
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.13%
0.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):